Loading clinical trials...
Loading clinical trials...
ICON1: Physician Treatment Decisions and Patient-Reported Outcomes in Pediatric Refractory Immune Thrombocytopenia
Conditions
Interventions
Second Line ITP agents
Locations
29
United States
Arkansas Children's Hospital
Little Rock, Arkansas, United States
Mattel Children's Hospital
Los Angeles, California, United States
Children's Hospital of Oakland
Oakland, California, United States
Children's Hospital of Orange County
Orange, California, United States
Lucile Packard Children's Hospital
Palo Alto, California, United States
UC Davis Medical Center
Sacramento, California, United States
Start Date
August 1, 2013
Primary Completion Date
April 1, 2017
Completion Date
April 1, 2017
Last Updated
May 21, 2020
NCT07104565
NCT07362238
NCT07362199
NCT07294365
NCT07175493
NCT06519565
Lead Sponsor
Boston Children's Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions